Jun Jiang

18PUBLICATIONS
64CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsCancer cell biologyObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 11, 2026
Clinical Outcomes, Treatment Patterns, and Molecular Heterogeneity of TFE3-Rearranged Renal Cell Carcinoma: A Multicenter Real-World Study.

|Feb 18, 2026
CCL5 hiCD4+ T Cells Regulate Macrophage Polarization and Promote Immunotherapy Response in Bladder Cancer.

Weiming Luo, Yapeng Wang, Haitao Wang

|Mar 19, 2025
Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancer.

Hanling Wang, Sulin Zhang, Qiang Pan

|Oct 22, 2024
Zinc ions activate AKT and promote prostate cancer cell proliferation via disrupting AKT intramolecular interaction.

Kangjunjie Wang, Min Chen, Shukun Yan

|Sep 06, 2024
Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers.

Baijun Dong, Jun-Yu Xu, Yuqi Huang

|Jul 18, 2024
Histone demethylase PHF8 promotes prostate cancer metastasis via the E2F1-SNAI1 axis.

Ze Wang, Peng Tang, Haiyang Xiao

Pageof 3

Frequent Collaborators

11 joint publications

Qiuli Liu

7 joint publications

Jun Qin

4 joint publications

Minjia Tan

4 joint publications

Weihua Lan